medline.ch Gastroenterologie Magen-Darm Entzündliche Darmerkrankungen

	[New data on appendectomies for ulcerative colitis]. MMW Fortschr Med Gross M. PMID: 42919070 [PubMed - in process]
	Review: optimizing rescue therapy in acute severe ulcerative colitis using infliximab pharmacokinetics-a practical guide for clinicians. J Crohns Colitis Con D, Li Wai Suen C, Choy M, Flegg JA, De Cruz P. PMID: 42918627 [PubMed - indexed for MEDLINE]
	Efficacy and Safety of Guselkumab in Patients with Crohn's Disease and Ulcerative Colitis: A Prospective Real-World Study. Clin Gastroenterol Hepatol Shafrir A, Choi D, Capucci LC, Hannett A, Tanouye J, Mathew AJ, Natt N, Dalal S, McDonald BD, Cleveland NK, Pekow J, Choden T, Cohen RD, Rubin DT. PMID: 42913902 [PubMed - as supplied by publisher]
	A real-world study of healthcare resource utilization and costs in patients with Crohn's disease and ulcerative colitis initiating ustekinumab treatment via Johnson & Johnson's BIOADVANCE program. Crohns Colitis 360 Targownik L, Pone E, Latour MG, Boyerahmadi K, Yang H, Ling J, Tehrani A, Golden S, Marshall JK. PMID: 42910390 [PubMed]
	Waiting time for surgery and health-related quality of life in patients with inflammatory bowel disease. Int J Colorectal Dis de la Croix H, Åberg H, Fledsberg S, Park J, Bengtsson J, Hermanson M. PMID: 42909622 [PubMed - indexed for MEDLINE]
	Dual therapy with tofacitinib and steroids for acute severe ulcerative colitis: a randomized double-blind placebo-controlled trial. J Crohns Colitis Arora U, Verma M, Madan D, Singh M, Kandasamy D, Narang H, Goyal M, Mahajan M, Mundhra SK, Prasad S, Mubunnu M, Goyal A, Panwar R, Sehgal T, Dash NR, Sharma R, Bhardwaj V, Kedia S, Makharia G, Ahuja V. PMID: 42909466 [PubMed - indexed for MEDLINE]
	Pitfalls in the Diagnosis and Classification of Crohn's Disease: Misdiagnosis, Overdiagnosis, and Misclassification. Turk J Gastroenterol Bilican G, Brezina B, Sharip MT, Subramanian S, Mutlu A, Karakan T, Cindoruk M, Kalkan Ç, Noor NM. PMID: 42909342 [PubMed - as supplied by publisher]
	Comparative Effectiveness of Vedolizumab and Ustekinumab in Biologic-Experienced Ulcerative Colitis: A Real-World Multicenter Study from the GÃ¼ntÃ¼rk Group. Turk J Gastroenterol Araz F, Sezgin O, Barutçu S, Ünal NG, Bengi G, Öz, Karao, Dervi, Özer B, Akpinar H, Oruç N, Gi, Atay K, Kara B, Kasap E, Çekin AH, Yilmaz N, Altinta, Ate, Üçbilek E, Harput ZN, , Dolu S, Mammadov E, Odaba, Tuncel ET, Ku, Ta, Akbay Harmandar F, Seydao, Aykut BM, Kara T, Çapar H, Çetin DD, Atar GE, Püren Yücel S. PMID: 42909316 [PubMed - as supplied by publisher]
	Serum X-C Motif Chemokine Ligand 1 Is Associated with Endoscopic Activity in Crohn's Disease: A Clinical Biomarker Study. Turk J Gastroenterol Li Z, Hao Y, Chen J, Liu X, Xu W, Cheng Y. PMID: 42909271 [PubMed - as supplied by publisher]
	Engineering extracellular vesicles for inflammatory bowel disease and colitis-associated colorectal cancer: from therapeutic innovation to clinical translation. Front Immunol Huang M, Yuan J, Muro P, Jin T, Mao F, Zhu W. PMID: 42909261 [PubMed - indexed for MEDLINE]
	Multi-cohort meta-analysis, single-cell and Mendelian randomization analyses with experimental validation identify RHBDF2 as a shared mediator of ulcerative colitis and blood-brain barrier disruption. Front Synaptic Neurosci Cheng J, Xu A. PMID: 42908994 [PubMed]
	Efficacy and Safety of Risankizumab Among Patients With Ulcerative Colitis in East Asia: A Post Hoc Analysis of Two Randomized Clinical Trials. J Gastroenterol Hepatol Takeuchi K, Cao Q, Ozeki K, Kang SB, Chou JW, Mallick M, Matsuda T, Morisset PA, Kalabic J, D'Cunha R, Ogawa Y, Zhang Y, Duan WR, Yeh YY, Hisamatsu T. PMID: 42908036 [PubMed - as supplied by publisher]
	Shared decision making in inflammatory bowel disease: a qualitative study with patients, gastroenterologists, and nurses. BMC Health Serv Res Schoefs E, Michiels L, Straetemans N, Ferrante M, Verstockt B, Sabino J, Debrun L, Loddewijkx E, Van Audenhove C, Vermeire S, Huys I. PMID: 42907825 [PubMed - indexed for MEDLINE]
	Very early onset inflammatory bowel disease in Jordan: a single-center case series of clinical, genetic, and therapeutic features. BMC Pediatr Altamimi E, Almomani H, Alsmadi A, Issi N, Shurman M. PMID: 42907806 [PubMed - indexed for MEDLINE]
	Risk factors and prediction model of renal dysfunction in patients with inflammatory bowel disease: a retrospective cohort study. BMC Gastroenterol Zhou Y, Sun K, Chen X, Shen X, Chen J, Wang L, Chen C, Wang H, Wan Y, Yang L, Li L. PMID: 42907758 [PubMed - indexed for MEDLINE]
	Comparative efficacy and safety of subcutaneous vedolizumab versus other targeted inflammatory bowel therapies in patients with moderate to severe ulcerative colitis: a network meta-analysis update. BMC Gastroenterol Jiang J, Wojtowicz A, Uyei J, Jin H, Lindsley K, Sanchirico M. PMID: 42907748 [PubMed - indexed for MEDLINE]
	Is hemorrhoidal surgery really unsafe in inflammatory bowel disease? Results from the HEAD-IBD multicenter study on behalf of IG-IBD. Tech Coloproctol Felice C, Pugliese D, Gallo G, Di Tanna GL, Ascolani M, Sica GS, Bellato V, Franco M, Scaldaferri F, Parisio L, Colombo F, Bondurri A, Guerci C, Aratari A, Festa S, Ascari F, Savarino EV, Grossi U. PMID: 42907681 [PubMed - indexed for MEDLINE]
	Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study. Dig Liver Dis Jeong TJ, Kwon Y, Kim YZ, Kim ES, Choe YH, Kim MJ. PMID: 42907314 [PubMed - as supplied by publisher]
	Poria cocos polysaccharides as a carbon source promotes the proliferation of Parabacteroides distasonis to ameliorate ulcerative colitis: A mechanistic study based on the secondary bile acid-TGR5 axis. Int J Biol Macromol Zhang Y, Fang Y, Chen Y, Chen Q, Liu W, Xu M, Xing L, Wang R, Wang L, Yu N, Peng D, Wang Y, Chen W. PMID: 42904778 [PubMed - indexed for MEDLINE]
	Upadacitinib in Colonic Crohn's Disease: A Narrative Review of Mechanistic Rationale, Clinical Trial Evidence, and Real-World Outcomes. Middle East J Dig Dis VatanParast Y. PMID: 42903373 [PubMed]

Artikel 1 - 20 / 59186

Seite 1 von 2960



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung